Convelo Therapeutics

0 followers


Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sc... Read more

Industries

Employees

11-50

Links


Org chart

Derrick Rossi
President & CEO
Collapse
Brad Lang
VP of Research, Biology Team Lead
Dan Factor
Director Of Discovery
Edmond Mok
Vice President of Finance (Consultant)
Samantha Stubblefield
VP, Operations & Program Management

Board & advisors

Bill Sanford
Chairman of the Board
Ronn Richard
Director
Jeffery Cohen
Chair of the Clinical Advisory Board
Robert Miller
Chair of Scienctific Advisory Board
Blane Walter
Advisor & Board Observer